MedTrace Logo

The Effects of Eight-Week Baduanjin Exercise on Chronic Low Back Pain and Disability Among Office Workers.

NCT07338045 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-05-19

No results posted yet for this study

Summary

Office workers often suffer from chronic low back pain due to long hours of sitting and poor posture. This study will test whether Baduanjin-a gentle, traditional Chinese exercise-can help reduce pain and improve physical function in office staff with long-standing back pain. Thirty participants will be randomly assigned to either practice Baduanjin for eight weeks or receive no special intervention. Researchers will measure changes in pain levels, movement ability, balance, posture, and daily functioning before and after the program. Baduanjin is a safe, low-cost, and easy-to-learn exercise that could be widely used in community health settings as a non-drug therapy for back pain.

Conditions

  • Low Back Pain
  • Baduanjin

Interventions

BEHAVIORAL

Baduanjin Exercise Program

A traditional Chinese qigong-based exercise program involving eight gentle movements designed to promote circulation, strengthen muscles, and improve balance. Participants will attend supervised sessions five times per week for 8 weeks, each lasting 45 minutes.

OTHER

Usual Care / No Structured Exercise

Participants will continue with their regular daily activities without receiving any structured exercise intervention or specific guidance related to low back pain management during the 8-week study period. They will be provided with information about the Baduanjin Exercise Program after the completion of all data collection, as part of an ethical follow-up measure.

Sponsors & Collaborators

  • Universiti Sains Malaysia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-15
Primary Completion
2026-07-31
Completion
2026-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07338045 on ClinicalTrials.gov